Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genetic screening of essential factors for cell-surface RNA

ABSTRACT: Genetic screening of essential factors for cell-surface RNA

PROVIDER: PRJEB88327 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR14838500.fastq.gz	Fastqsanger.gz
	ERR14838495.fastq.gz	Fastqsanger.gz
	ERR14838496.fastq.gz	Fastqsanger.gz
	ERR14838497.fastq.gz	Fastqsanger.gz
	ERR14838498.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

High-throughput high-multiplexed screening for splicing factors

Project description:High-throughput high-multiplexed screening for splicing factors

| PRJNA854891 | ENA

Dissecting the Genetic Underpinnings of Essential Tremor

Project description:Dissecting the Genetic Underpinnings of Essential Tremor

| PRJNA402111 | ENA

Loss-of-function genetic screening identifies ALDOA as an essential driver for hepatocellular carcinoma cell growth under hypoxia

Project description:Loss-of-function genetic screening identifies ALDOA as an essential driver for hepatocellular carcinoma cell growth under hypoxia

| PRJNA708271 | ENA

Non-essential mRNA processing factors

Project description:Set of experiments done on yeast deletion strains of various non-essential mRNA processing factors. Keywords = splicing

2010-05-27 | E-GEOD-35 | biostudies-arrayexpress

Optimized CRISPR-Cas12a platform for combinatorial drop-out genetic screening (RNA-seq)

Project description:Combinatorial genetic perturbations have been utilized to identify synthetic sick/lethal genetic interactions for cancer drug target discovery. Current methods for high-throughput combinatorial genetic screening are inefficient and cumbersome. Here we developed a simple, robust, and high-performance CRISPR-Cas12a-based approach for unbiased, combinatorial genetic screening in cancer cells.

2020-06-08 | GSE141130 | GEO

STAMPScreen: An Integrated Pipeline for Mammalian Genetic Screening

Project description:STAMPScreen: An Integrated Pipeline for Mammalian Genetic Screening

| PRJNA754432 | ENA

Suppressor mutant screening lacking growth-essential tRNA modification in bacteria

Project description:Suppressor mutant screening lacking growth-essential tRNA modification in bacteria

| PRJEB56046 | ENA

STAMPScreen: An Integrated Pipeline for Mammalian Genetic Screening

Project description:With the recent advancements in genome editing, next generation sequencing (NGS), and scalable cloning techniques, scientists can now conduct genetic screens at unprecedented levels of scale and precision. With such a multitude of technologies, there is a need for a simple yet comprehensive pipeline to enable systematic mammalian genetic screening. In this study, we develop novel algorithms for target identi fication and a toxin-less Gateway cloning tool, termed MegaGate, for library cloning which, when combined with existing genetic perturbation methods and NGS-coupled readouts, enable versatile engineering of relevant mammalian cell lines. Our integrated pipeline for Sequencing-based Target Ascertainment and Modular Perturbation Screening (STAMPScreen) can thus be utilized for a host of cell state engineering applications.

2021-08-14 | GSE182088 | GEO

Pseudomonas aeruginosa, fap genetic variants, surface associated proteomics

Project description:The surface associated proteomics of different P aeruginosa fap genetic variants were evaluated. The bacteria were grown on the glass wool, the biomass was extracted from glass wool and the surface influenced planktonics(SIP)biomass was collected.

2022-11-27 | PXD033853 | Pride

CRISPR-StAR, a paradigm leveraging internal controls, empowers genetic screening in vivo (batch 2)

Project description:Pooled genetic screening with CRISPR/Cas9 has enabled genome-wide high-resolution assignment of genes to phenotypes. To assess the effect of a given genetic perturbation, each sgRNA must be evaluated in hundreds of cells to overcome stochastic genetic drift and obtain robust results. In complex models that display particularly high heterogeneity, such as organoids or tumors transplanted into mice however, sufficient representation typically requires unreasonable scaling, thus preventing genome-wide screens at high resolution. Here we present CRISPR-StAR, a screening paradigm that overcomes intrinsic and extrinsic heterogeneity as well as genetic drift in bottlenecks by leveraging internal controls generated through activating sgRNAs only in half of the progenies of each cell. We use CRISPR-StAR to reveal in vivo-specific genetic dependencies in a genome-wide screen in mouse melanoma. Benchmarking to a conventional screening setup highlights the improved data quality this technology delivers. We anticipate CRISPR-StAR to set a new standard for genetic screening in complex models, foremost in vivo.

2024-11-05 | GSE262308 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data